Buckyballs form up into quasicrystal layer


quasicrystals

The fullerenes assemble in pentagonal tiles that produce patterns that do not repeat © ACS

Flat, two-dimensional layers of molecules structured like quasicrystals – crystals that show order without repeating patterns –  have been made for the first time by scientists in the UK and Japan.

These scanning tunnelling electron microscopy images show buckyballs, or molecules of C60, that have been sputter coated onto the surface of a quasicrystalline alloy of aluminium, copper and iron at very high temperatures. The buckyballs form a lattice of pentagonal ‘Penrose tile’ shapes as they interact with iron atoms in the crystal and adsorb to its surface. Dan Shechtman was awarded the 2011 Nobel prize in chemistry for his discovery of quasicrystals in 1982.

The team, led by Joe Smerdon at the University of Central Lancashire, also created similar two-dimensional quasicrystalline layers out of rod-shaped pentacene molecules on the surface of silver–indium–ytterbium quasicrystals, consistent with those predicted in recent theoretical models. They say this template-based approach to making quasicrystals could potentially be scaled up to produce larger systems.


Related Content

Quasicrystals Scoop Prize

28 October 2011 Feature

news image

This year's Nobel laureate in chemistry fought hard to win acceptance of his discovery: quasicrystals. Laura Howes tells how ...

Molecules mimic mesmerising mathematics

22 April 2014 Research

news image

Computer modelling predicts formation of molecular quasicrystals

Most Read

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

Chemists zinc up ‘aromatic’ metal cubes

2 March 2015 Research

news image

Metal-organic clusters share electrons between eight covalently linked metal atoms

Most Commented

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

Hepatitis C drug patent challenged in Europe

19 February 2015 Business

news image

Campaign group says Gilead’s expensive blockbuster sofosbuvir is not innovative enough to warrant a patent